1. Switzerland Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Idorsia Ltd

Idorsia Ltd

IDRSF
Idorsia LtdUS flagOther OTC
5.75
USD
- -
- -
1.47BMarket Cap

Total Valuation

Idorsia Ltd carries a market capitalization of 1.47B, placing it among publicly traded companies globally. Its enterprise value stands at 1.58B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.47B
Enterprise Value1.58B

Share Statistics

Idorsia Ltd currently has 204.09M shares outstanding.

Shares Outstanding204.09M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 1.66, and the price-to-book ratio stands at -0.11.

PE RatioN/A
PS Ratio1.66
PB Ratio-0.11
P/TBV Ratio-0.31
P/FCF Ratio-2.16
P/OCF Ratio-1.43

Enterprise Valuation

EV / Sales7.28
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Idorsia Ltd maintains a current ratio of 0.73, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -114.17, indicating conservative leverage, while an interest coverage ratio of -6.45 demonstrates limited ability to service its debt obligations.

Current Ratio0.73
Quick Ratio0.24
Debt / Equity-114.17
Debt / EBITDA-7.53
Interest Coverage-6.45

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-22.82
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)9.29
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover0.56

Taxes

Over the trailing twelve months, Idorsia Ltd has paid 4.13M in income taxes, reflecting an effective tax rate of 0.62.

Income Tax4.13M
Effective Tax Rate0.62

Stock Price Statistics

Idorsia Ltd's stock has gained approximately 209.13978% over the past 52 weeks. The 50-day moving average sits at 4.79, while the 200-day moving average is 4.63.

Beta (5Y)N/A
52-Week Price Change209.13978%
50-Day Moving Average4.79
200-Day Moving Average4.63
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Idorsia Ltd generated 217.23M in revenue and converted that into -133.30M in net income, yielding earnings per share of -0.49. EBITDA reached -173.05M, while operating income came in at -173.05M.

Revenue217.23M
Gross Profit179.84M
Operating Income-173.05M
Pretax Income-129.17M
Net Income-133.30M
EBITDA-173.05M
EBIT-173.05M
Earnings Per Share (EPS)-0.49

Balance Sheet

Idorsia Ltd holds 82.16M in cash and equivalents against 1.30B in total debt, resulting in a net debt position of 1.11B. Total book value stands at -3.34B, with working capital of -94.46M providing operational flexibility.

Cash & Cash Equivalents82.16M
Total Debt1.30B
Net Debt1.11B
Equity (Book Value)-3.34B
Book Value Per Share-17.70
Working Capital-94.46M

Cash Flow

Idorsia Ltd produced -250.65M in operating cash flow over the past twelve months. After subtracting -11.88M in capital expenditures, free cash flow totaled -262.53M - equivalent to -1.39 per share.

Operating Cash Flow-250.65M
Capital Expenditures-11.88M
Free Cash Flow-262.53M
FCF Per Share-1.39

Margins

Idorsia Ltd operates with a gross margin of 82.79, reflecting its pricing power and cost economics. The operating margin of -79.66 and net profit margin of -61.36 provide insight into operational efficiency.

Gross Margin82.79
Operating Margin-79.66
Pretax Margin-59.46
Profit Margin-61.36
EBITDA Margin-79.66

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-25.46
FCF Yield-46.31

Stock Splits

Idorsia Ltd's most recent stock split took place on October 14, 2020 with a 1000:1013 split ratio.

Last Split Date10/14/2020
Split Ratio1000:1013

Scores

Idorsia Ltd posts an Altman Z-Score of -10.91, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-10.91